Objective

Healthy lives based on personalized disease prevention and management (i.e., precision medicine) require that we understand the biology of disease progression and regression over time. To address this challenge, BRAINCURES has integrated proprietary data and analyses with existing knowledge to unravel the biological program behind learning and memory. This biological intelligence powers the BRAINCURES Discovery Engine, a novel in silico approach to de-risk and accelerate drug discovery. For example, their unique biological framework acts as molecular GPS to increased preclinical and clinical success by extracting biology-based opportunities for pipeline/program management, repurposing and molecular stratification from multiple starting points (e.g., compounds, diseases, AI-outputs and clinical trials). The company is now working towards proof-of-concept partnerships aimed at enabling better, safer and faster precision medicines for the 1 in 10 people affected with brain diseases (e.g., Alzheimer's Disease, Depression, Pain). www.braincures.com